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Background: The aim of the present study was to review the contemporary presentation and evolution of management of
neck paragangliomas.
Methods: Forty-one neck paragangliomas operated on in 36 patients over a 44 year period were included in the current
report. The study period was divided into two parts, the first three decades (1964-1989), during which the current
management techniques were evolved, and the last two decades (1990-2008).
Results: Patients presented with a palpable neck mass (n  17), cranial nerve (CN) palsy (n  3) or both (n  6), or the
lesion was an incidental finding (n 14). The use of cross-section imagingmodalities (n 24) increased from 35% during
the first part of the study to 95% during the second part of the study (P < .001). Preoperative embolization (introduced
in 1979) was performed in 60% (median size 4.3 cm for embolized vs 3 cm [P .02], for non-embolized tumors). During
the first study period, the frequency of Shamblin group II/III tumors was 95% compared with a frequency of 42%
during the second study period (P < .001, odds ratio 25), median blood loss was 600 ml and 150 ml, respectively (P
.001) and the transfusion rate was 44% and 5%, respectively (P  .008). The incidence of temporary and permanent new
CN deficits postoperatively was 22.5% and 10%, respectively, and was similar during the two study periods. Three tumors
were malignant, based on lymph node involvement (n  1) or development of late metastases (n  2).
Conclusions: In themodern era, neck paragangliomas can bemanaged with a low incidence of long-term sequelae. Smaller,
asymptomatic, and incidentally detected tumors are currently the most common presentation pattern. (J Vasc Surg
2009;49:1365-73.)Paragangliomas, also known as chemodectomas, are
rare tumors that arise from chemoreceptor cells that
form the carotid and aortic bodies and the glomus
jugulare, but can be also located in the ganglion nodo-
sum of the vagus, the middle ear, and other sites
throughout the body. Carotid body tumors are the most
common form of neck paragangliomas (NPs). According
to the operative volume statistics of the Accreditation
Council for Graduate Medical Education (ACGME) for
Vascular Surgery trainees, most academic centers in this
country do not resect more than one tumor of this type
per year,1 although variations due to referral patterns do
exist.2-4
Unless they are found incidentally, NPs are indolent
until they grow large enough to cause symptoms like a
palpable mass, cranial nerve palsy, or both. Although usu-
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Vascular Surgery.doi:10.1016/j.jvs.2009.01.059ally benign, resection of locally advanced tumors can be
complicated by a high incidence of cranial nerve (CN)
injury due to direct involvement or close proximity.2,5-9 In-
volvement of the carotid artery can occasionally necessitate
carotid artery reconstruction.2,5,8 Because the mortality and
neurological morbidity of tumor resection with internal ca-
rotid artery ligationwasworse than the natural history of these
slowly growing tumors,10-12 expectant management was the
standard treatment before the era of carotid artery reconstruc-
tion.13 Currently, however, uncomplicated resection of these
tumors is usually feasible as a result of careful preoperative
planning and the use of several adjuncts, including cross-
sectional imaging,14,15 selective preoperative emboliza-
tion,16 and mandibular subluxation,17,18 use of bipolar
cautery,19,20 selective carotid shunting based on intraoper-
ative cerebral monitoring,21 and carotid artery reconstruc-
tion when deemed necessary.2,5,22
The aim of the present study was to review the contem-
porary presentation and the evolution of management strate-
gies for these complex tumors over the last five decades.
METHODS
Study design. This is a retrospective study of patients
with neck paragangliomas identified from the prospectively
maintained Division of Vascular Surgery,23 and Depart-
ment of Pathology databases, using the appropriate Inter-
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and Current Procedural Terminology (CPT) codes and
free-text search terms, as appropriate. Patient information
was retrieved from these databases, paper charts, and hos-
pital electronic records. To identify trends reflecting the
evolution of methods and techniques used in the evaluation
and management of NPs,16 patients were divided into two
groups, those treated during the early years (from 1964 to
1989 inclusive, during which the current management
techniques were evolved) and the late years (between 1990
and 2008) of the study. The division of the study subjects
into these two intervals was based on major changes in
diagnostic modalities and techniques and the accumulation
of experience in managing these rare tumors during the
early study period. The Institutional Review Board of the
Hospital approved the study.
Preoperative evaluation. Preoperative diagnostic test-
ing included angiography, the only imaging method em-
ployed at the beginning of the series and cross-sectional
imaging. Ultrasonography became available in the mid
1970’s, followed by computerized tomography (Fig 1,
online only) in the early 1980’s, and magnetic resonance
imaging (Fig 2, online only) in the late 1980’s. Cross-
sectional imaging, however, was not routinely employed
until the second period of the study. Initially angiography
was performed via the direct antegrade carotid puncture,
but during the 1980’s the retrograde femoral or brachial
approach was adopted. More recently, computerized to-
mographic angiography has been our preferred imaging
modality. Preoperative embolization to reduce intraopera-
tive bleeding (Fig 3, online only) was introduced in 1979
and performed selectively by an Interventional Radiologist
(and more recently a Neuro-Radiologist) in 21 cases there-
after, usually 24 hours before excising NPs presenting
unusual technical difficulties16 (ie, tumors that were large,
belonged to Shamblin groups 2 or 3 or extended cranially).
Gelfoam particles followed by spring coils delivered
through a transarterial approach were used early in our
series,16 but more recently microcoils have been used ex-
clusively (GDC-10 coil [Boston Scientific, Natick, Mass],
Hydrocoil [MicroVention/Terumo, Aliso Viego, Calif],
and TruFill Orbits [Cordis, Miami Lake, Fla]).
Surgical procedures. Based on tumor location as doc-
umented by preoperative imaging, excision is performed
through a standard anterior sternocleidomastoid incision,
as previously described by our group (Fig 4, online only),16
or an infratemporal fossa approach for glomus jugulare
tumors. Once the tumor is visualized, assessment of carotid
artery involvement is performed; in such cases dissection is
typically directed to achieve control of the common carotid
artery, proximally and the internal and external carotid
arteries, distally before attempting tumor mobilization.
Distal internal carotid exposure is facilitated utilizing stan-
dard techniques (eg, ligation of the occipital artery branch
to the sternocleidomastoid muscle, division of the posterior
belly of the digastric muscle). Depending on tumor loca-
tion, size, and degree of carotid artery involvement, a
variety of operative adjuncts were adopted during the firstpart of the study and thereafter used selectively (Fig 5).
These adjuncts included: mandibular subluxation (intro-
duced in 1987) for tumors extending cranially,17,18 auto-
transfusion for large tumors,12 and intraoperative cerebral
monitoring with electroencephalography (EEG) (intro-
duced in 1985) with selective shunting of the internal
carotid artery as needed for carotid artery clamping and/or
reconstruction.21 To minimize CN injury, bipolar cautery
is used;20 adjacent non-involved CNs are protected and
mobilized off the tumor as required; this is achieved by
dissecting through the tumor pseudocapsule. To facilitate
mobilization of larger tumors, external carotid artery
(ECA) ligation is performed if necessary.2 For advanced
tumors encasing the internal carotid artery (Fig 6) or
densely adherent to the internal and/or common carotid
arteries without a dissection plane between the tumor and
the vessel adventitia (white line of Gordon-Taylor), carotid
artery excision is performed. Carotid artery reconstruction
is usually performed with an interposition saphenous vein
graft from the common carotid artery to the internal ca-
rotid. The Shamblin classification scheme is used to classify
tumors in relation to carotid artery involvement.24 Accord-
ing to this classification, group 1 tumors can be resected
Fig 5. Flow chart of diagnostic modalities and adjunctive tech-
niques recommended to improve safety of neck paraganglioma
resection.without significant trauma to the vessel wall or to the tumor
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are more adherent to the adventitia and, although their
dissection is much more difficult, it is still possible to excise
them without sacrificing the vessel. Group 3 tumors com-
pletely encase the artery and are usually best treated by
sacrifice of the involved artery.
Outcome. Information on short and long-term out-
come was retrieved from the above mentioned prospective
databases, paper charts, and hospital electronic records and
also the internet based social security death index. Perma-
nent vocal cord paralysis due to recurrent laryngeal nerve or
CN X injury was managed with injection or medialization
laryngoplasty. Severe dysphagia due to CN IX or X injury
was managed with percutaneous endoscopic gastrostomy
(PEG), while for the purposes of airway protection in
bilateral vocal cord palsy (previous contralateral palsy) a
tracheostomy was considered.
Statistics. All data were entered into a Microsoft Of-
fice Access database (Microsoft Inc., Redmond, Washing-
ton, USA) and analyzed with SPSS 14.0 for Windows
(SPSS Inc., Chicago, Illinois, USA). The Kolmogorov-
Smirnov test was used to test numerical data for normal
distribution; normally distributed data were expressed as
mean and standard deviation and compared with t test,
otherwise they were expressed as median and interquartile
range (IQR) and the Mann-Whitney test was used. Cate-
gorical data were analyzed with the chi-square (or Fisher’s
exact test where appropriate) and odd ratios (with 95%
Fig 6. Excision of a Shamblin group 3 carotid body tu
excision followed by an interposition (common to intern
carotid artery.confidence interval; CI) were calculated to compare riskbetween groups. Two-tailed statistical tests were always
used and a P value less than .05 was considered as statisti-
cally significant.
RESULTS
Patient presentation. During the study period (1964-
2008), 41 neck paragangliomas were managed in 36 pa-
tients (Table I). These were carotid body tumors in 76%,
but also vagal paragangliomas, glomus jugulare tumors,
one cervical sympathetic chain paraganglioma, and one
neck paraganglioma of undetermined organ of origin. One
patient with a vagal paraganglioma had a coexisting small
carotid body tumor excised during the same operative
session. Patient demographics are shown in Table II. Para-
that necessitated en-bloc tumor and carotid bifurcation
tid artery) saphenous vein bypass to replace the encased
Table I. Pathology, by histologic type, in 36 patients
with 41 neck paragangliomas
Histology type No Percentage
Carotid body tumor* 31 76
Vagal paraganglioma* 4 10
Glomus jugulare tumor 4 10
Cervical sympathetic chain paraganglioma 1 2
Undetermined origin 1 2
Total 41 100
*One patient with a vagal paraganglioma had a coexisting small carotid body
tumor.mor
al carogangliomas located in the middle ear (n  56), nasophar-
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requiring concomitant craniotomy (n  3), irrespective of
carotid artery involvement, were excluded. Patient presen-
tation is summarized in Table II. Symptomatic patients
presented with a neck mass (n  17), CN palsy (n  3) or
both (n  6). The tumor was discovered as an incidental
finding seen on imaging studies performed for other rea-
sons in the remaining 14 patients. One of the patients in
whom the tumor was an incidental finding presented with
ipsilateral hemispheric transient ischemic attacks due to a
70% internal carotid artery stenosis per angiogram; histol-
ogy revealed that the artery lumen was partially obliterated
by focally calcified and ulcerated atherosclerotic plaque.
Significantly more patients presented with a neck mass
(with or without CN palsy) in time period one (n  16)
than in time period two (n  7), compared with patients
whose tumors were incidental findings (n  4 and n  10,
respectively, P .015). Sixteen CNs (VII, n 6; VIII, n
1; IX, n 1; X or recurrent laryngeal, n 4; XI, n 1; XII,
n 2; and cervical sympathetic chain, n 1), range 1-4, in
nine patients were noted to be affected preoperatively.
Palpable neck tumors with CN palsy were significantly
larger (median tumor size, 5.3 cm; IQR, 4-8 cm) compared
with those that had isolated CN palsy, a mass or no symp-
toms (3.4 cm; IQR, 2.6-5 cm, P  .045). Carotid body
Table II. Patient demographics and presentation patterns
St
1964-1989 (n  21)
Age (mean  sd, years) 49.7  16.6
Gender (male/female) 12/9
Race (African American/Caucasian) 5/16
Side (left/right) 7/14
Presentation
Neck mass 11 (52%)
Cranial nerve palsy 1 (5%)
Neck mass with cranial nerve palsy 5 (24%)
Incidental finding 4 (19%)
Previous tumor biopsy or exploration 6 (32%)*
Bilateral paraganglioma 3 (14%)
Family history of paraganglioma 1 (6%)*
*Data unavailable in two patients.
Table III. Preoperative evaluation and management of pa
1964-1989 (n 
Imaging
Angiography 20 (95%)
Cross-sectional imaging* 6 (35%)
Ultrasound 3
Computerized 3
Tomography
Magnetic resonance imaging 0
Preoperative embolization (only after 1978) 12 (75%)
*Available in the late 1970’s; 19 patients had two or three tests.tumors were associated with fewer CN palsies comparedwith the remaining NPs (median number, 0 vs 1; P 
.003).
Preoperative work-up. Preoperative diagnostic eval-
uation included angiography (n  33), cross-sectional im-
aging (ultrasound [US], computed tomography [CT], or
magnetic resonance imaging [MRI]; n 24), or both. The
use of cross-sectional imaging increased from the first to the
second periods of the study from 35% to 95%, respectively
(P  .001; Table III), with more than one modality being
used in 19 patients. Preoperative embolization was per-
formed in 60% (21 of 35) of tumors managed after 1978;
ECA branches feeding the tumor were embolized in all
cases, while in one patient additional blood supply from the
vertebral artery was also embolized. The median size of
embolized tumors was 4.3 cm vs 3 cm for non-embolized
tumors (P  .02). In one patient, the embolization proce-
dure was complicated by contrast-induced encephalopathy
manifested as transient bilateral cortical blindness (Anton’s
syndrome); in another patient with bilateral carotid body
tumors transient discomfort with chewing occurred after
embolizing both ECAs. This masticatory “claudication”
was presumed, due to an extensive decrease in the blood
supply to the masseter muscle from occluding both ECAs.
These symptoms slowly resolved postoperatively.
Surgical procedures. Operative details are shown in
tudy period
eriod
1990-2008 (n  19) P value All years (n  40)
56.9  16.0 .17 53.1  16.5
6/13 .11 18/22
6/13 .58 11/29
11/8 .12 18/22
6 (32%) 17 (42%)
2 (10%) 3 (8%)
1 (5%) 6 (15%)
10 (53%) .026 14 (35%)
3 (16%) .45 9 (21%)
3 (16%) 1.00 6 (15%)
2 (12%) 1.00 3 (9%)
s with neck paragangliomas
dy period
1990-2008 (n  19) P value All years (n  40)
13 (68%) .04 33 (83%)
18 (95%) .001 24 (67%)
3 6
15 18
10 10
9 (47%) 0.096 21 (60%)by s
udy ptient
Stu
21)Table IV. The tumor was approached through a neck
toring
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4). During the first study period, one patient with a history
of vocal cord palsy due to prior excision of a contralateral
carotid body tumor involving CN X underwent a prophy-
lactic tracheostomy. A difference in utilization rates for
operative adjuncts was observed between the two study
periods, withmandibular subluxation and EEGmonitoring
been more frequent during the second period; a reverse
trend in ICA clamping and shunting rates was also seen.
Tumors during the first period of this study were signifi-
cantly larger and more advanced than in the second period.
During the first study interval, the frequency of Shamblin
group 2/3 tumors was 95% and during the second 42%
(P  .001; odds ratio, 25). External carotid ligation was
utilized almost exclusively during the first period of this
study, when it was performed in half of all patients. Carotid
reconstruction (bypass with a Dacron graft, n  1 or
saphenous vein graft, n 4, ICA patch angioplasty using an
ECA flap, n  1, and ECA-ICA transposition, n  1) or
Table IV. Operative management of neck paraganglioma
S
1964-1989 (n  21
Approach
Neck incision 19 (90%)
Infratemporal fossa approach* 2 (10%)
Operative adjunctives
Mandibular subluxation 2 (10%)
EEG monitoring 5 (24%)
ICA clamping** 7 (37%)
ICA shunting# 4 (21%)
§
Operative findings
Tumor size (median, IQR, in cm) 4.5 (3.4-6.2)
Shamblin group 1/2/3** 1/11/7
Operative procedures
ECA ligation 10 (48%)
ICA reconstruction 4 (19%)
ICA ligation 2 (10%)
Blood loss (median, IQR, in ml) 600 (275-1,725)
Transfusion (n, %)# 8 (44%)
Transfused blood units (median, IQR) 0 (0-4)
Transfused blood units (total) 34
IQR, Interquartile range.
*For glomus jugulare paragangliomas.
**Not applicable in 2 patients.
#Unknown in 2 patients.
§Routine shunting in all four patients in the absence of intraoperative moni
Table V. Postoperative cranial nerve injury
1964-1989
Permanent CN injury, no of patients (%) 3 (1
Temporary CN injury, no of patients (%) 4 (1
All CN injuries, no of patients (%) 7 (3
All CN injuries, sum (median no) of affected nerves 14 (0
CN, Cranial nerve.ICA ligation (n  2, because of history of previous radia-tion in one case) was necessary in 82% of Shamblin group 3
tumors. The difference in median blood loss between the
first and second intervals of the study, 600 ml and 150 ml,
respectively, was significant (P  .001) as was the transfu-
sion rate, 44% and 5%, respectively (P  .008). Complete
tumor resection was accomplished in 38 patients (95%). In
one patient, residual tumor involving CNs IX-XII was left
behind. In another elderly patient with a number of co-
morbidities treated during the 1960’s, a preoperative plan
to excise a tumor encasing the ICA was abandoned during
neck exploration with lymph node biopsy only.
Postoperative complications. Twenty-two CNs in
13 patients demonstrated evidence of dysfunction, postop-
eratively (Table V); these were CN VII branches (n  4,
including the marginal mandibular branch, n  3 and the
marginal mandibular, buccal, and temporal branches, n 
1), CN IX (n 3), CN X (n 5), recurrent laryngeal nerve
(n 2), CN XI (n 2), CN XII (n 3), and sympathetic
chain (n  3). Two cases of CN X palsy were observed in
eriod
1990-2008 (n  19) P value All years (n  40)
17 (90%) 36 (90%)
2 (10%) 1.00 4 (10%)
4 (21%) .40 6 (15%)
7 (37%) .37 12 (30%)
3 (16%) .14 10 (26%)
0 (0%) .11 4 (10%)
3.0 (2.3-4.5) .016 4.0 (3.0-6.0)
11/4/4 .002 12/15/11
1 (5%) .003 11 (28%)
3 (16%) 1.00 7 (18%)
0 (0%) .49 2 (5%)
150 (75-300) .001 300 (138-1,000)
1 (5%) .008 9 (25%)
0 (0-0) .004 0 (0-0.5)
1 35
.
Study period
21) 1990-2008 (n  19) P value All tumors (n  40)
) 1 (5.3%) .61 4 (10%)
5 (26%) .71 9 (22.5%)
6 (32%) .91 13 (32.5%)
8 (0) .61 22 (0)s
tudy p
)(n 
4.3%
9%)
3%)
)patients operated on for vagus paraganglioma. An addi-
JOURNAL OF VASCULAR SURGERY
June 20091370 Kakkos et altional patient with a vagal paraganglioma, causing dyspha-
gia and hoarseness preoperatively, had worsening of these
symptoms postoperatively requiring placement of a gas-
trostomy tube. Three more patients without preoperative
dysphagia (all with carotid body tumors) required tempo-
rary feeding tube placement because of CN IX (n  2) or
CN X (n  1) injury. Persistent vocal cord paralysis due to
permanent (preoperative or postoperative) CN X or recur-
rent laryngeal nerve palsy was managed with injection
laryngoplasty in five patients with good results, except one
of them who required an additional medialization laryngo-
plasty with a Silastic implant. New permanent CN deficits
were seen postoperatively in 10% of all patients, while new
temporary CN deficits were seen in 22.5%. There was no
association between baseline patient and tumor character-
istics (including size, location, group, and symptoms or
study period) and new postoperative CN injury; this oc-
curred in 33% of carotid body tumors and 30% of the
remaining tumor types (P  1.00), while its incidence in
Shamblin group 1, 2 and 3 tumors was 25%, 40%, and 36%,
respectively. There was an association between adjunctive
treatment modalities and new postoperative CN injury,
with NPs that required mandibular subluxation or ICA
clamping being associated with an increased incidence of
CN injury (67% and 50%, respectively) compared with
those that did not require thesemaneuvers (27% (P .075)
and 25% (P  .24), respectively]. The median size of
tumors in patients who developed permanent postoperative
CN injuries was larger (8 cm) than in patients who sus-
tained no such injuries (3.8 cm), (P  .08) and tumors
developing permanent postoperative CN injury were more
frequently malignant (50%) and larger (5.9 cm) compared
with those removed with no neurological sequelae (2.8%
malignant, P  .022 and 4 cm, P  .19, respectively).
Additional complications included neck wound hematoma
requiring re-operation in two patients, thigh wound hema-
toma (following saphenous vein harvesting, n  1, man-
aged conservatively), and stroke, one fatal in a patient who
had ICA ligation, a second one in a patient requiring
carotid bypass who made a partial recovery (both during
the first decade of the study), and a third stroke that
occurred two weeks postoperatively in a patient requiring
carotid bypass; this was patent and the patient made a full
recovery (during the second part of the study). There were
no other deaths.
Long-term follow-up. Three tumors (7.5%, two ca-
rotid body tumors and one vagal paraganglioma) were
malignant, based on lymph node involvement (confirmed
histologically, n  1) or development of late metastases
(n  2). The first of the two patients who developed late
metastases, developed these six years postoperatively at the
L2 vertebra; local tumor recurrence was also evident. The
vertebral body metastases were initially managed with ra-
diotherapy and later with L2 vertebrectomy and anterior
spinal fixation with sequential embolization. The local re-
currence was managed expectantly with the patient living
five more years. The second patient developed pulmonary
metastases four years after resection of a vagal paragangli-oma. These have beenmanaged expectantly and the patient
is still alive after two years of follow-up. Two additional
patients developed local recurrence. One patient, 17 years
after complete excision of a carotid body tumor, developed
local recurrence that was re-excised. This second procedure
was complicated by permanent vocal cord paresis and tem-
porary dysphagia due to apparent CN X injury and a
temporary CN XII injury. He is recurrence-free three years
later. The second patient, four years after complete excision
of a glomus jugulare tumor, developed a local intracranial
recurrence. Finally, the patient with known residual disease
after excision of a vagal paraganglioma and a small carotid
body tumor (treated with radiosurgery) developed late
tumor progression with palsy of CNs IX-XII. Ten and
twenty year patient survival was 81% and 63%, respectively.
DISCUSSION
In this study, we reviewed the presentation and man-
agement patterns of NPs treated over a period of five
decades. Significantly smaller and less advanced NPs with
more precise preoperative imaging were seen in the most
recent period, and were associated with a significant reduc-
tion in operative blood loss and transfusion rates. At the
beginning of the series, preoperative diagnostic testing
included only angiography initially via the direct antegrade
carotid puncture. After a decade, cross-sectional imaging
became available, initially in the form of ultrasonography in
the mid 1970’s, followed by computerized tomography in
the early 1980’s andmagnetic resonance imaging in the late
1980’s. Adjuncts to facilitate resection and prevent compli-
cations were also introduced, including preoperative embo-
lization in 1979, intraoperative cerebral monitoring with
EEG and selective shunting of the internal carotid artery in
1985, and mandibular subluxation in 1987.
Over the course of the entire study, the frequency of
NPs detected incidentally rose from 19% to 53%. The
widespread utilization of non-invasive imaging methods
explains the increased frequency of asymptomatic (and
smaller) tumors observed during the second part of our
study and could also be responsible for the older age of this
group. More importantly, cross-sectional imaging modali-
ties (CT scanning and MR imaging) have significantly
improved preoperative planning. The goals for preopera-
tive imaging, as summarized by Iafrati and O’Donnell, are
to secure the diagnosis (biopsy being contraindicated be-
cause of the highly vascular nature of these tumors), to
define local tumor extension to anticipate the need for
extended exposure or carotid resection, to evaluate the
presence of concomitant atherosclerotic carotid disease,
potentially requiring endarterectomy, to identify synchro-
nous tumors either ipsilateral or in the contralateral carotid,
and finally to determine of the need for preoperative tumor
embolization.25 A correct preoperative diagnosis is impor-
tant to minimize unnecessary neck exploration and/or
biopsies;20,26,27 reflecting the utility of preoperative imag-
ing, the rate of unnecessary tumor exploration and/or
biopsies in our series fell from 32% in the early period to
16% in the later period, consistent with the experience of
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ning or MR imaging) was almost universal during the
second part of our study. Similarly, in a recent multicenter
study multiple cross-sectional imaging modalities, includ-
ing ultrasound were frequently used.7 In contrast, ultra-
sound was rarely used alone in our series, because it cannot
provide details on tumor extension. Angiography was used
less often during the second part of our series, which
indicates a trend for selective usage, consistent with previ-
ous reports,7 mainly for the purposes of preoperative em-
bolization,25,29 and rarely to assess for ICA invasion,29 or
to perform an ICA balloon occlusion test on the rare
occasion ICA ligation is considered instead of reconstruc-
tion. However, some authorities continue to use angiogra-
phy routinely.28 In the modern era, high-resolution CT
angiography is probably the best initial test because it
combines the advantages of both axial CT scanning and
angiography. Magnetic resonance imaging should be re-
served for cases where precise delineation of tumor extent is
required, because of its better soft tissue definition.30
Preoperative embolization was used in 60% in our
series. Variable rates, up to 40%-50%, have been reported
by others.4,14,31,32 Consistent with our previous experi-
ence,16 and the literature,14,32 embolized tumors in the
current study were bigger than non-embolized tumors.
Reduced blood loss in embolized mid-sized tumors has
been reported;6 however, there is debate as to whether the
benefits of embolization outweigh its risks,32 mainly TIA
and stroke,33,34 as well as its additional costs. We currently
recommend that preoperative embolization be considered
only for NPs presenting unusual technical difficulties –
tumors that are large (5cm in size), belong to Shamblin
group 3, or extend significantly cranially.
Operative challenges and hazards, recognized for over
a century, can be anticipated from preoperative imaging
studies and managed accordingly.2,24 Mandibular sublux-
ation, reserved for large tumors that usually extend crani-
ally,18 was performed in 15% of our cases; this method
displaces the vertical ramus of the mandible forward by 2 to
3 cm transforming the normal triangular shaped operative
field into a rectangular one, widening its apex, thus provid-
ing additional space for safe exposure and control of the
distal ICA.18 The Shamblin classification scheme reliably
predicts the need for ICA reconstruction or ligation. Ca-
rotid reconstruction to resect an advanced tumor that
encases the ICA was performed in 18% of our patients.
Similar rates of carotid reconstruction, in the range of 6% to
33%, have been reported by others.2,4,5,8,20,26,33,35,36 Ca-
rotid reconstruction is also required more often with larger
tumors.22
Postoperative stroke was observed in 7.5% of our pa-
tients; this is associated with carotid reconstruction or ICA
injury and thrombosis, and has been reported to occur in
0% to 16% of patients.2,9,20,26,32,36 There are a variety of
mechanisms for stroke in patients undergoing NP resec-
tion. Carotid clamping or ligation (as in one of our pa-
tients) can lead to brain ischemia or embolism especially in
case of inadequate anticoagulation. Thrombosis of a ca-rotid reconstruction (graft or other type), either early or
delayed is usually due to technical reasons, but can result
from venous graft endothelial injury or inadequate use or
resistance to conventional antiplatelets, etc. In order to
minimize stroke occurrence in patients requiring carotid
reconstruction, we recommend monitored anticoagula-
tion, neuromonitoring, and selective shunting intraopera-
tively, and antiplatelet use with ultrasound surveillance of
the reconstruction postoperatively. Two cases of postoper-
ative stroke complicated carotid reconstruction in our se-
ries. The first one was observed in a patient who had an
interposition Dacron graft placed in the 60’s (exact stroke
mechanism unknown) while the second one (manifested
on postoperative day 14) was observed in a patient with a
patent venous interposition graft. To prevent stroke related
to temporary carotid clamping, selective internal carotid
shunting has been used in most series.36,37 This is currently
our preferred method; we routinely use EEG monitoring
when resecting Shamblin group 2 or 3 tumors or in other
high-risk situations where carotid clamping and/or recon-
struction seems likely.
Obviously, tumors that extend up to the skull base
represent a special challenge that require the assistance of
surgeons experienced with the appropriate exposure(s).38
Once frequently performed, ligation of the external carotid
artery to facilitate tumor mobilization is rarely performed
today. The smaller size of tumors being treated in the
modern era and the availability of preoperative emboliza-
tion has made this maneuver largely unnecessary.
Blood loss and transfusion rates were significantly re-
duced in the second part of our series. Consistent with our
study, blood loss in the modern era is generally low,14,34,39
but can average as much as 2,200 ml in Shamblin group 3
tumors.8 Transfusion rates as high as 50% were reported in
older series,9 when cross-matching for 4-6 units of blood
was frequently advised.10,20 Compared with a standard
dissection technique where the tumor is stripped away from
the bifurcation in a caudocranial fashion, a craniocaudal
direction of dissection has been shown to be associated with
reduced blood loss,39 very similar with the amount we
reported during the second part of our study. Proponents
of this approach feel that it may be superior because it
allows for control of feeding branches of the external ca-
rotid before dissecting the tumor proper.
The incidence of postoperative CN dysfunction in our
study was 32.5% and remained constant throughout the
study period, a finding consistent with other reports in the
literature.2 Cranial nerve injury is not uncommon in carotid
surgery, including both endarterectomy40-42 and carotid
body tumor excision.2,6,7,14,20,26,32,33,35,36 Most series of
carotid body tumors report a 40% incidence of CN
injury,2,6,26,32,36 but rates lower than 20%7,35 or as high as
50%14,33 have been documented. Permanent CN injury
occurs in 8%-39% of patients,5,6,9,14,26,33 on average
20%.5,6,26 In our study, such injury rates were in the lower
range, although we considered preoperative CN palsies,
even if they were permanent, separately. Cranial nerve
injury has been reported more often with advanced tu-
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or vagal paragangliomas.44 In our series, mandibular sub-
luxation and ICA clamping were associated with an in-
creased incidence of CN injury compared with those that
did not require these maneuvers. Both of these maneuvers
are associated with more difficult tumor resections. The
region around the distal ICA has been described by Hallett
and colleagues as the most dangerous dissection zone be-
cause of its proximity to a number of CNs which must be
protected.2 Prompt recognition and management of CN
IX or X injury is imperative because the resulting aspiration
can be fatal,42 and more common in case of delayed or no
use of PEG.44,45 Prophylactic tracheostomy, once a com-
mon practice,45,46 is currently performed selectively, only if
airway complications arise.9
Resection of NP has a mortality rate of 1%-2%,7,47
which, in a recent large study, was increased to 8.8% in
patients requiring concomitant carotid reconstruction.47
These data justify early tumor extirpation, which is addi-
tionally justified because of the potential for malignancy.
The malignancy rate was 7% in our series and has reported
to vary between 4%-14% in the literature4,5,7,9,11,26,34,35
Because of the high complication rate of surgery that is
performed for a slowly growing tumor (on average 4 mm
per annum),10 with a low malignant potential, there is
debate on the need to resect all NPs.48,49 Counterargu-
ments include the fact that complete resection is almost
always possible,49 recurrence is rare, with reported rates
varying between 4%-15%,20,31 and most important, resec-
tion can prevent tumor-related CN palsies. Because the
latter usually develop late, conservative management has
been proposed in selected patients with a short life expect-
ancy.
Management of NPs did involve a variety of special-
ists in our series. A multidisciplinary approach is recom-
mended,20,22,34,50 which may explain the better outcomes
achieved in academic centers.47 Such an approach does
require a number of specialists, including radiologists to
provide detailed preoperative imaging and perform preop-
erative tumor embolization when necessary. Otolaryngo-
logic surgeons are helpful to evaluate patients for cranial
nerve dysfunction preoperatively and to manage postoper-
ative vocal cord problems due to recurrent laryngeal nerve
or CN X injury. The infratemporal approach for glomus
jugulare tumors is also performed by otolaryngologic sur-
geons. Mandibular subluxation is performed by a maxillo-
facial surgeon. Postoperative swallowing difficulties may
call for a percutaneous gastrostomy tube, which can be
placed by an endoscopist or radiologist. All these specialists
assist the vascular surgeon to safely excise the tumor and
manage postoperative complications.
In conclusion, NPs can be managed with a low inci-
dence of long-term sequelae. Diagnosis of smaller and
asymptomatic tumors is increasingly common. Improved
outcomes have resulted from more complete preoperative
imaging and the routine use of several operative adjuncts,
including pre-operative embolization, mandibular sublux-
ation, and intraoperative EEG monitoring.AUTHOR CONTRIBUTIONS
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vertebra.
with bilateral carotid body tumors.
coiling with significantly reduced vascularity.
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slices (left side) and sagittal reconstructions (right side) of a large
right-side carotid body tumor extending to the level of the C1Fig 2, online only. Magnetic resonance imaging scan of a patientFig 3, online only. a. Diagnostic preoperative right carotid ar-
tery angiogram of the patient with the carotid body tumor shown
in Fig 1, which demonstrates a hypervascular tumor, splaying the
carotid bifurcation. b.Appearance following tumor embolization/
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